Vivendi (VIV) Given a €25.00 Price Target at UBS Group

UBS Group set a €25.00 ($29.07) price target on Vivendi (EPA:VIV) in a research note published on Friday, www.boersen-zeitung.de reports. The brokerage currently has a buy rating on the stock.

Several other equities research analysts have also weighed in on VIV. Credit Suisse Group set a €24.20 ($28.14) price objective on Vivendi and gave the stock a buy rating in a report on Tuesday, October 16th. Kepler Capital Markets set a €21.00 ($24.42) price objective on Vivendi and gave the stock a neutral rating in a report on Tuesday, July 31st. Deutsche Bank set a €30.00 ($34.88) price objective on Vivendi and gave the stock a buy rating in a report on Tuesday, July 31st. Cfra set a €24.00 ($27.91) price objective on Vivendi and gave the stock a neutral rating in a report on Tuesday, July 31st. Finally, Goldman Sachs Group set a €30.00 ($34.88) target price on Vivendi and gave the stock a buy rating in a research note on Tuesday, July 31st. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Vivendi currently has a consensus rating of Buy and an average price target of €24.96 ($29.02).

Shares of VIV opened at €21.72 ($25.26) on Friday. Vivendi has a fifty-two week low of €16.85 ($19.59) and a fifty-two week high of €24.87 ($28.92).

Vivendi Company Profile

Vivendi SA operates as a content media and communication company in France, rest of Europe, the United States, and internationally. It operates through Universal Music Group, Canal+ Group, Havas, Gameloft, Vivendi Village, and New Initiatives segments. The Universal Music Group segment is involved in the sale of digital and physical recorded music; and exploitation of music publishing rights, as well as provides artist and merchandising services.

See Also: Why does a company issue an IPO?

Analyst Recommendations for Vivendi (EPA:VIV)

Receive News & Ratings for Vivendi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivendi and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply